Details of the Drug

General Information of Drug (ID: DM1X1QZ)

Drug Name

18F-fluorothymidine

Synonyms

3'-Deoxy-3'-[18F]fluorothymidine; AC1L9P5W; SCHEMBL10017180; MOLI001306; NSC743144; NSC-743144; radiolabeled form of 3'-deoxy-3'-fluorothymidine (FLT) (NSC 140025)

Indication

Disease Entry	ICD 11	Status	REF
Breast cancer	2C60-2C65	Phase 2	[1]

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C10H13FN2O4
Canonical SMILES: CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)F
InChI: InChI=1S/C10H13FN2O4/c1-5-3-13(10(16)12-9(5)15)8-2-6(11)7(4-14)17-8/h3,6-8,14H,2,4H2,1H3,(H,12,15,16)/i11-1
InChIKey: UXCAQJAQSWSNPQ-KXMUYVCJSA-N

Cross-matching ID

PubChem CID: 450772
TTD ID: D0A1RP

Drug ADMET Endpoint Profile (DAE)^NEW

Click to Jump to the Detailed DAE Information of This Drug

References

1	ClinicalTrials.gov (NCT00572728) 3'-Deoxy-3'-18F Fluorothymidine PET/CT in Predicting Response To Chemotherapy Before Surgery in Patients With Locally Advanced Breast Cancer. U.S. National Institutesof Health.